The IBD&me Randomized Controlled Trial

• Patient satisfaction[ Time Frame: one day after the clinic visit ]
  Patient satisfaction as measured by four domains of the Patient Satisfaction Questionnaire relating to communication, general satisfaction, interpersonal manner, and time spent with the doctor (PSQ-18)
• Disease control and IBD-related quality of life[ Time Frame: at baseline and two months after the clinic visit ]
  Disease control and IBD-related quality of life, as measured by the IBD-Control questionnaire
• Initiation or switch of a treatment[ Time Frame: at baseline and two months after the clinic visit ]
  Questionnaire about IBD therapy use

Navigating the risk-benefit profiles of the various biologic options approved for inflammatory bowel disease (IBD) can be challenging for patients who are considering biologic therapies as a treatment option. Thus, there is a need for simple and efficient tools that elicit individual preferences and support the patient-provider interaction. The principal objective of this study is to assess the impact of an online decision aid called IBD&me on patient perceptions of shared-decision making as compared to a standardized education arm.

• Other: Online decision aid called IBD&me
  Patients randomized to IBD&me will be directed to go through the website 10 days before their clinic appointment, and will be asked to bring their personalized report with them to their upcoming visit.
• Other: Standardized educational material
  Patients randomized to the control arm will be sent a PDF file corresponding to the CCFA's online resource 10 days before their clinic appointment, and will be asked to bring it with them to their upcoming visit.

• Experimental: Online decision aid called IBD&me
  IBD&me is an online, freely available tool that allows patients to explore decision-making around biologic therapies for IBD at their own pace. It includes an educational component and an interactive exercise with a series of ratings tasks that generates a personalized preferences report for patients to share and discuss with their physician.
• Active Comparator: Standardized educational material
  PDF file corresponding to the CCFA's online resource on biologic therapies, which is a well-researched and clearly presented overview of IBD biologic therapies, but without an active shared-decision making component.